ALT Q2 2020 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$721,636-55.6% YoY

Gross Profit

$721,636100.0% margin

Operating Income

-$18M-2552.3% margin

Net Income

-$17M-2323.5% margin

EPS (Diluted)

$-0.94

QoQ Revenue Growth

-67.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$330,510

Balance Sheet

Total Assets

$103M

Total Liabilities

$23M

Stockholders' Equity

$80M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$721,636	$2M	-55.6%
Gross Profit	$721,636	-$1M	+154.7%
Operating Income	-$18M	-$4M	-418.7%
Net Income	-$17M	-$3M	-395.1%